Mineralized collagen scaffolds for regenerative engineering applications.
Journal
Current opinion in biotechnology
ISSN: 1879-0429
Titre abrégé: Curr Opin Biotechnol
Pays: England
ID NLM: 9100492
Informations de publication
Date de publication:
Apr 2024
Apr 2024
Historique:
received:
28
08
2023
revised:
26
01
2024
accepted:
27
01
2024
medline:
18
3
2024
pubmed:
26
2
2024
entrez:
25
2
2024
Statut:
ppublish
Résumé
Collagen is a primary constituent of the tissue extracellular matrix. As a result, collagen has been a common component of tissue engineering biomaterials, including those to promote bone regeneration or to investigate cell-material interactions in the context of bone homeostasis or disease. This review summarizes key considerations regarding current state-of-the-art design and use of collagen biomaterials for these applications. We also describe strategic opportunities for collagen biomaterials to address a new era of challenges, including immunomodulation and appropriate consideration of sex and other patient characteristics in biomaterial design.
Identifiants
pubmed: 38402689
pii: S0958-1669(24)00016-8
doi: 10.1016/j.copbio.2024.103080
pii:
doi:
Substances chimiques
Biocompatible Materials
0
Collagen
9007-34-5
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
103080Subventions
Organisme : NIAMS NIH HHS
ID : R01 AR077858
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE030491
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM070421
Pays : United States
Informations de copyright
Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.